Shilpa Medicare informs about updates

17 Nov 2025 Evaluate
Shilpa Medicare has informed about the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD).

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

288.70 1.30 (0.45%)
02-Feb-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1313.00
Zydus Lifesciences 877.15
Lupin 2124.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×